Food and Drug Administration
Center for Drug Evaluation and Research
Endocrinologic and Metabolic Drugs Advisory Committee
January 15, 2003
The following people have enrolled to speak at the Open Public Hearing at today’s session:
Abbey S. Meyers - National Organization for Rare Disorders, Inc.
Melissa Bryant - Charlotte, NC
Stephen E. Holland - National MPS Society, Inc.
Linda L. Day - Sheridan, Montana
Mark A. Dant - Carrollton, Texas
J.E. Wraith, MB, ChB, FRCPHC - Royal Manchester Children's Hospital
Denise Dengel - Seattle, Washington
Eric Merrell - Herculaneum, Missouri
In addition, letters and e-mails were submitted from the public. Copies of these have been provided to the Committee and are available for public viewing in the two binders at the Information Desk. They will also be posted on the FDA website after the meeting and are considered part of the permanent meeting record.